Linus Pauling Institute

We’re pleased to share the latest research from the Dr. Fred Stevens lab!

Their Phase 2 clinical trial found that xanthohumol, a natural compound from hops, moved patients with active Crohn's disease into remission within 4 weeks, with no adverse effects.

🔎 Check it out in the latest Molecular Nutrition & Food Research: https://onlinelibrary.wiley.com/doi/10.1002/mnfr.70501

Shout out to College of Health - Oregon State University and LPI alum Paige Jamieson for her work on this exciting research!

To learn more about the research–and the possibilities it may hold for millions of people managing inflammatory bowel disease–check out our Research Insider newsletter hub: https://lpi.oregonstate.edu/research-insider/xanthohumol-crohns-disease-clinical-trial

From Hops to Healing: A Natural Compound Moves Patients with Crohn's Disease Toward Remission in Phase 2 Trial | Linus Pauling Institute An LPI-led Phase 2 trial shows xanthohumol, a natural compound from hops, reduced Crohn's disease activity to remission levels with no adverse effects.